Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04868383 · ClinicalTrials.gov registry record · NA
Using Smart Phone Technology to Support PrEP Uptake and Adherence
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT04868383: Completed NA study, sponsored by University of Virginia.
NCT04868383 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04868383, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This is a single arm pilot study of a new smartphone app to support adherence to PrEP medication for HIV prevention in public clinics in Virginia.
Primary Outcome
Overall percentage of PrEP medication adherence
Interventions
- BEHAVIORAL Use of smart phone technology to support medication adherence and uptake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-12-30 |
| Phase | NA |
What the finished NCT04868383 record still lists
NCT04868383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Use of smart phone technology to support medication adherence and uptake is the first listed.
NCT04868383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04868383 about?
NCT04868383 is a clinical study titled "Using Smart Phone Technology to Support PrEP Uptake and Adherence". This is a single arm pilot study of a new smartphone app to support adherence to PrEP medication for HIV prevention in public clinics in Virginia.
What is the current status of trial NCT04868383?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2019-01-01. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT04868383?
The interventions under investigation include: Use of smart phone technology to support medication adherence and uptake (BEHAVIORAL).
Who is sponsoring clinical trial NCT04868383?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04868383's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI